| 000 | 01840 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517234641.0 | ||
| 264 | 0 | _c20190607 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1878-7568 | ||
| 024 | 7 |
_a10.1016/j.actbio.2018.08.035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuo, Yanhong | |
| 245 | 0 | 0 |
_aCX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy. _h[electronic resource] |
| 260 |
_bActa biomaterialia _c10 2018 |
||
| 300 |
_a317-330 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAptamers, Nucleotide |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aBenzothiazoles _xpharmacology |
| 650 | 0 | 4 |
_aCell Nucleolus _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aEndocytosis _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aNaphthyridines _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Ribosomal _xgenetics |
| 650 | 0 | 4 |
_aTissue Distribution _xdrug effects |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aYang, Min | |
| 700 | 1 | _aDu, Zhenya | |
| 700 | 1 | _aFeng, Chuhan | |
| 700 | 1 | _aXing, Chen | |
| 700 | 1 | _aWu, Yanping | |
| 700 | 1 | _aXie, Zhenhua | |
| 700 | 1 | _aZhang, Fang | |
| 700 | 1 | _aHuang, Laiqiang | |
| 700 | 1 | _aZeng, Xiaowei | |
| 700 | 1 | _aChen, Hongbo | |
| 773 | 0 |
_tActa biomaterialia _gvol. 79 _gp. 317-330 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.actbio.2018.08.035 _zAvailable from publisher's website |
| 999 |
_c28793055 _d28793055 |
||